2023
Prostate cancer risk stratification using magnetic resonance imaging–ultrasound fusion vs systematic prostate biopsy
Khajir G, Press B, Lokeshwar S, Ghabili K, Rahman S, Gardezi M, Washington S, Cooperberg M, Sprenkle P, Leapman M. Prostate cancer risk stratification using magnetic resonance imaging–ultrasound fusion vs systematic prostate biopsy. JNCI Cancer Spectrum 2023, 7: pkad099. PMID: 38085220, PMCID: PMC10733209, DOI: 10.1093/jncics/pkad099.Peer-Reviewed Original ResearchConceptsMagnetic resonance imaging-ultrasound fusionMRF-TBLow-risk diseaseSystematic biopsyLower riskRisk groupingProstate biopsyActive surveillanceHigh riskProstate cancer risk stratificationIntermediate-risk criteriaIntermediate-risk diseaseSystematic prostate biopsyCancer risk stratificationPrimary study objectiveNCCN guidelinesImage-guided approachLocalized cancerRisk stratificationBenign findingsProstate cancerClinical riskDiagnostic yieldRetrospective analysisBiopsyPersonalizing approaches to the management of metastatic hormone sensitive prostate cancer: role of advanced imaging, genetics and therapeutics
Lokeshwar S, Choksi A, Haltstuch D, Rahman S, Press B, Syed J, Hurwitz M, Kim I, Leapman M. Personalizing approaches to the management of metastatic hormone sensitive prostate cancer: role of advanced imaging, genetics and therapeutics. World Journal Of Urology 2023, 41: 2007-2019. PMID: 37160450, DOI: 10.1007/s00345-023-04409-9.Peer-Reviewed Original ResearchConceptsMetastatic hormone-sensitive prostate cancerAndrogen deprivation therapyHormone-sensitive prostate cancerSensitive prostate cancerPositron emission tomographyConventional computerized tomographyDocetaxel chemotherapyClinical trialsProstate cancerCombination of ADTBackbone of treatmentCytoreductive radical prostatectomySequencing of therapyFirst-line treatmentEvaluation of patientsClinical practice guidelinesOngoing clinical trialsAndrogen receptor antagonistPubMed Medline databaseDeprivation therapyInitial managementOverall survivalStaging evaluationBone scanRandomized trialsEjaculatory Preserving Holmium Laser Enucleation of the Median Lobe: Preserving Sexual Function While Improving Urinary Outcomes
Press B, Gardezi M, Kim D, Lokeshwar S, Rahman S, Siev M, Ghiraldi E, Lerner L, Kellner D. Ejaculatory Preserving Holmium Laser Enucleation of the Median Lobe: Preserving Sexual Function While Improving Urinary Outcomes. Urology 2023, 173: 175-179. PMID: 36646177, DOI: 10.1016/j.urology.2022.12.035.Peer-Reviewed Original ResearchConceptsAmerican Urological Association symptom scoreHolmium laser enucleationLaser enucleationUrinary functionUrinary incontinenceRetrograde ejaculationSymptom scoresPost-void residual volumeMedian lobePreservation of ejaculationVoid residual volumeIntravesical prostatic protrusionStress urinary incontinenceHigh bladder neckPerioperative outcomesMedian ageNormal ejaculationPostoperative qualityBladder neckCase seriesSingle surgeonUrinary outcomesLife scoresEjaculatory dysfunctionSexual function
2022
“En-Bloc” Enucleation With Early Apical Release Compared to Standard Holmium Laser Enucleation of the Prostate: A Retrospective Pilot Study During the Initial Learning Curve of a Single Surgeon
Press B, Ghiraldi E, Kim DD, Nair H, Johnson K, Kellner D. “En-Bloc” Enucleation With Early Apical Release Compared to Standard Holmium Laser Enucleation of the Prostate: A Retrospective Pilot Study During the Initial Learning Curve of a Single Surgeon. Urology 2022, 165: 275-279. PMID: 35063465, DOI: 10.1016/j.urology.2022.01.011.Peer-Reviewed Original ResearchConceptsEn-bloc approachInitial learning curveHolmium laser enucleationSingle surgeonLaser enucleationApical releaseLearning curvePost-operative complicationsRetrospective pilot studyLength of stayEn bloc techniqueEn-bloc enucleationOperative efficiencyMann-Whitney UPatient demographicsMajor complicationsOperative timeConsecutive menFunctional outcome
2021
Utility of PSA Density in Predicting Upgraded Gleason Score in Men on Active Surveillance With Negative MRI
Press BH, Khajir G, Ghabili K, Leung C, Fan RE, Wang NN, Leapman MS, Sonn GA, Sprenkle PC. Utility of PSA Density in Predicting Upgraded Gleason Score in Men on Active Surveillance With Negative MRI. Urology 2021, 155: 96-100. PMID: 34087311, DOI: 10.1016/j.urology.2021.05.035.Peer-Reviewed Original ResearchConceptsPSA densityActive surveillanceConfirmatory biopsyPathologic upgradeNegative MRIProstate volumeProstate cancerFavorable intermediate-risk prostate cancerNegative baselineIntermediate-risk prostate cancerLow-grade prostate cancerLower prostate volumeMedian PSA densityNormal baseline MRIUpgraded Gleason scoreCohort of patientsSubset of patientsLarge academic centerPI-RADS 2Intensity of surveillanceAbility of PSABiopsy upgradeGG1 cancerGleason upgradeMedian PSA
2019
Postoperative Complications After Robotic Partial Nephrectomy
Connor J, Doppalapudi SK, Wajswol E, Ragam R, Press B, Luu T, Koster H, Tamang TL, Ahmed M, Lovallo G, Munver R, Stifelman MD. Postoperative Complications After Robotic Partial Nephrectomy. Journal Of Endourology 2019, 34: 42-47. PMID: 31588795, DOI: 10.1089/end.2019.0434.Peer-Reviewed Original ResearchConceptsRobotic partial nephrectomyPostoperative complicationsArterial malformationOverall incidencePartial nephrectomyUnivariate analysisClavien-Dindo systemInstitutional review boardPerioperative variablesProspective cohortRetrospective cohortNephrectomy databaseNephrometry scoreSelective embolizationArteriovenous fistulaContemporary seriesPostoperative imagingRisk factorsSurgical complexityUrine collectionComplicationsCohortIncidenceReview boardTumor complexity
2018
The ultrasound characteristics of regions identified as suspicious by magnetic resonance imaging (MRI) predict the likelihood of clinically significant cancer on MRI–ultrasound fusion‐targeted biopsy
Press B, Rosenkrantz AB, Huang R, Taneja SS. The ultrasound characteristics of regions identified as suspicious by magnetic resonance imaging (MRI) predict the likelihood of clinically significant cancer on MRI–ultrasound fusion‐targeted biopsy. BJU International 2018, 123: 439-446. PMID: 30415476, DOI: 10.1111/bju.14615.Peer-Reviewed Original ResearchConceptsCancer detection rateMagnetic resonance imagingGleason scoreHypoechoic regionsInstitutional review board-approved databaseResonance imagingProstate-specific antigen densityFusion-targeted biopsyMultivariable regression analysisDetection rateProstate cancer detectionSignificant PCaUltrasonography findingsSingle surgeonSystematic biopsyProstate biopsySignificant cancerUnivariate analysisAntigen densityMRI suspicionSingle radiologistHigh riskUltrasound characteristicsRegion of interestBiopsyDevelopment of a Novel Prognostic Risk Score for Predicting Complications of Penectomy in the Surgical Management of Penile Cancer
Velazquez N, Press B, Renson A, Wysock JS, Taneja S, Huang WC, Bjurlin MA. Development of a Novel Prognostic Risk Score for Predicting Complications of Penectomy in the Surgical Management of Penile Cancer. Clinical Genitourinary Cancer 2018, 17: e123-e129. PMID: 30377070, DOI: 10.1016/j.clgc.2018.09.018.Peer-Reviewed Original ResearchConceptsNovel prognostic risk scoreNovel risk scorePrognostic risk scoreRisk scoreSurgical managementStepwise logistic modelSurgeons National Surgical Quality Improvement ProgramNational Surgical Quality Improvement ProgramSuperficial surgical site infectionSurgical Quality Improvement ProgramAppreciable complication rateImproved preoperative counselingUrinary tract infectionSurgical site infectionQuality Improvement ProgramPredicting ComplicationsPenile cancerSurgical complicationsTotal penectomyTract infectionsComplication rateSite infectionOverall incidenceRetrospective reviewRisk stratificationDiscriminative Ability of Commonly Used Indexes to Predict Adverse Outcomes After Radical Cystectomy: Comparison of Demographic Data, American Society of Anesthesiologists, Modified Charlson Comorbidity Index, and Modified Frailty Index
Meng X, Press B, Renson A, Wysock JS, Taneja SS, Huang WC, Bjurlin MA. Discriminative Ability of Commonly Used Indexes to Predict Adverse Outcomes After Radical Cystectomy: Comparison of Demographic Data, American Society of Anesthesiologists, Modified Charlson Comorbidity Index, and Modified Frailty Index. Clinical Genitourinary Cancer 2018, 16: e843-e850. PMID: 29550199, DOI: 10.1016/j.clgc.2018.02.009.Peer-Reviewed Original ResearchConceptsPerioperative adverse outcomesCharlson Comorbidity IndexComorbidity indexAdverse eventsRadical cystectomyAdverse outcomesFrailty indexBladder cancerSurgeons National Surgical Quality Improvement ProgramDemographic dataNational Surgical Quality Improvement ProgramDiscriminative abilityModified Charlson Comorbidity IndexAnesthesiologists Physical Status Classification SystemSurgical Quality Improvement ProgramPhysical Status Classification SystemDemographic factorsInfectious adverse eventsModified Frailty IndexOutcome variablesPatient comorbidity indexPerioperative outcome variablesPredictive demographic factorsMinor adverse eventsSevere adverse events